The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer

The prognostic role of estrogen receptors in lung cancer is not validated. Results from patients with early stage non-small lung cancer patients indicate a prognostic role of estrogen receptor 1 (ESR1) mRNA expression in these patients. Automated RNA extraction from paraffin and RT-quantitative PCR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Atmaca, Akin (VerfasserIn) , Al‐Batran, Salah-Eddin (VerfasserIn) , Wirtz, Ralph Markus (VerfasserIn) , Werner, Dominique (VerfasserIn) , Zirlik, Sabine (VerfasserIn) , Wiest, Gunther (VerfasserIn) , Eschbach, Corinna (VerfasserIn) , Claas, Silke (VerfasserIn) , Hartmann, Arndt (VerfasserIn) , Ficker, Joachim Hans (VerfasserIn) , Jäger, Elke (VerfasserIn) , Brueckl, Wolfgang Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2014
In: International journal of cancer
Year: 2013, Jahrgang: 134, Heft: 10, Pages: 2314-2321
ISSN:1097-0215
DOI:10.1002/ijc.28571
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/ijc.28571
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.28571
Volltext
Verfasserangaben:Akin Atmaca, Salah-Eddin Al‐Batran, Ralph Markus Wirtz, Dominique Werner, Sabine Zirlik, Gunther Wiest, Corinna Eschbach, Silke Claas, Arndt Hartmann, Joachim Hans Ficker, Elke Jäger and Wolfgang Michael Brueckl

MARC

LEADER 00000caa a2200000 c 4500
001 1727346513
003 DE-627
005 20220818180529.0
007 cr uuu---uuuuu
008 200818r20142013xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.28571  |2 doi 
035 |a (DE-627)1727346513 
035 |a (DE-599)KXP1727346513 
035 |a (OCoLC)1341355837 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Atmaca, Akin  |d 1970-  |e VerfasserIn  |0 (DE-588)130656704  |0 (DE-627)505291843  |0 (DE-576)298325713  |4 aut 
245 1 4 |a The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer  |c Akin Atmaca, Salah-Eddin Al‐Batran, Ralph Markus Wirtz, Dominique Werner, Sabine Zirlik, Gunther Wiest, Corinna Eschbach, Silke Claas, Arndt Hartmann, Joachim Hans Ficker, Elke Jäger and Wolfgang Michael Brueckl 
264 1 |c 2014 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.08.2020 
500 |a First published: 31 Oct 2013 
520 |a The prognostic role of estrogen receptors in lung cancer is not validated. Results from patients with early stage non-small lung cancer patients indicate a prognostic role of estrogen receptor 1 (ESR1) mRNA expression in these patients. Automated RNA extraction from paraffin and RT-quantitative PCR was used for evaluation of tumoral ESR1 and progesterone receptor (PGR) mRNA expression. The test cohort consisted of 31 patients with advanced or metastatic non-small cell lung cancer (NSCLC) patients, treated in a first-line registry trial. For validation, 53 patients from a randomized multicentre first-line study with eligible tumor samples were evaluated. There was no significant correlation of ESR1 expression with clinical characteristics. ESR1 high expression was of significant positive prognostic value in the training set with a median overall survival (OS) of 15.9 versus 6.2 months for high versus low ESR1 expression patients (p = 0.0498, HR 0.39). This could be confirmed in the validation cohort with a median OS of 10.9 versus 5.0 months in ESR1 high versus low patients, respectively (p = 0.0321, HR 0.51). In the multivariate analysis adjusted for histological subtype, gender, age and performance status, ESR1 expression remained an independent prognostic parameter for survival in both cohorts. In contrast to ESR1, PGR expression was not able to separate prognostic groups or to predict outcome significantly (for OS; p = 0.94). Our study shows that ESR1 mRNA as assessed by qPCR represents a reliable method for detecting ESR1 expression in NSCLC and that ESR1 expression is an independent prognostic factor in metastatic NSCLC. 
534 |c 2013 
650 4 |a estrogen receptor 1 
650 4 |a metastatic 
650 4 |a non-small cell lung cancer 
650 4 |a progesterone receptor 
700 1 |a Al‐Batran, Salah-Eddin  |e VerfasserIn  |4 aut 
700 1 |a Wirtz, Ralph Markus  |e VerfasserIn  |4 aut 
700 1 |a Werner, Dominique  |e VerfasserIn  |4 aut 
700 1 |a Zirlik, Sabine  |e VerfasserIn  |4 aut 
700 1 |a Wiest, Gunther  |e VerfasserIn  |4 aut 
700 1 |a Eschbach, Corinna  |e VerfasserIn  |0 (DE-588)1084029723  |0 (DE-627)84823426X  |0 (DE-576)456161449  |4 aut 
700 1 |a Claas, Silke  |e VerfasserIn  |4 aut 
700 1 |a Hartmann, Arndt  |e VerfasserIn  |4 aut 
700 1 |a Ficker, Joachim Hans  |e VerfasserIn  |4 aut 
700 1 |a Jäger, Elke  |e VerfasserIn  |4 aut 
700 1 |a Brueckl, Wolfgang Michael  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 134(2014), 10, Seite 2314-2321  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer 
773 1 8 |g volume:134  |g year:2014  |g number:10  |g pages:2314-2321  |g extent:8  |a The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer 
856 4 0 |u https://doi.org/10.1002/ijc.28571  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.28571  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200818 
993 |a Article 
994 |a 2014 
998 |g 1084029723  |a Eschbach, Corinna  |m 1084029723:Eschbach, Corinna  |d 910000  |d 950000  |d 950900  |e 910000PE1084029723  |e 950000PE1084029723  |e 950900PE1084029723  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 7 
999 |a KXP-PPN1727346513  |e 3740744340 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"8 S."}],"person":[{"role":"aut","given":"Akin","family":"Atmaca","display":"Atmaca, Akin"},{"display":"Al‐Batran, Salah-Eddin","role":"aut","given":"Salah-Eddin","family":"Al‐Batran"},{"display":"Wirtz, Ralph Markus","family":"Wirtz","role":"aut","given":"Ralph Markus"},{"display":"Werner, Dominique","family":"Werner","given":"Dominique","role":"aut"},{"display":"Zirlik, Sabine","given":"Sabine","role":"aut","family":"Zirlik"},{"display":"Wiest, Gunther","role":"aut","given":"Gunther","family":"Wiest"},{"display":"Eschbach, Corinna","given":"Corinna","role":"aut","family":"Eschbach"},{"display":"Claas, Silke","given":"Silke","role":"aut","family":"Claas"},{"display":"Hartmann, Arndt","role":"aut","given":"Arndt","family":"Hartmann"},{"display":"Ficker, Joachim Hans","role":"aut","given":"Joachim Hans","family":"Ficker"},{"display":"Jäger, Elke","family":"Jäger","role":"aut","given":"Elke"},{"display":"Brueckl, Wolfgang Michael","given":"Wolfgang Michael","role":"aut","family":"Brueckl"}],"title":[{"title_sort":"validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer","title":"The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer"}],"name":{"displayForm":["Akin Atmaca, Salah-Eddin Al‐Batran, Ralph Markus Wirtz, Dominique Werner, Sabine Zirlik, Gunther Wiest, Corinna Eschbach, Silke Claas, Arndt Hartmann, Joachim Hans Ficker, Elke Jäger and Wolfgang Michael Brueckl"]},"recId":"1727346513","id":{"eki":["1727346513"],"doi":["10.1002/ijc.28571"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"note":["Gesehen am 18.08.2020","First published: 31 Oct 2013"],"relHost":[{"title":[{"title_sort":"International journal of cancer","title":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer"}],"titleTranslated":[{"translated":"Journal international du cancer"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"display":"International Union against Cancer","role":"isb"}],"id":{"doi":["10.1002/(ISSN)1097-0215"],"eki":["269532781"],"issn":["1097-0215"],"zdb":["1474822-8"]},"origin":[{"publisher":"Wiley-Liss","dateIssuedKey":"1966","dateIssuedDisp":"1966-","publisherPlace":"Bognor Regis"}],"disp":"The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancerInternational journal of cancer","recId":"269532781","pubHistory":["1.1966 -"],"titleAlt":[{"title":"Predictive oncology"}],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"part":{"year":"2014","issue":"10","volume":"134","pages":"2314-2321","extent":"8","text":"134(2014), 10, Seite 2314-2321"}}]} 
SRT |a ATMACAAKINVALIDATION2014